Pasadena Private Wealth’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,286,833
Closed -$31.9M 313
2026
Q1
$31.9M Buy
+2,286,833
New +$32.1M 4.41% 4

Other funds holding BTAL

Pasadena Private Wealth's BTAL Position: Q2 2026 in Review

Pasadena Private Wealth sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 2,286,833 shares — an estimated $31.9M sold.

Pasadena Private Wealth first reported a position in BTAL in Q1 2026 and held it in 1 quarter. The position peaked at $31.9M in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Pasadena Private Wealth reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
  • Pasadena Private Wealth sold 2,286,833 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $31.9M.
  • Pasadena Private Wealth first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2026 and held it in 1 quarter.
  • Pasadena Private Wealth's AGF US Market Neutral Anti-Beta Fund position peaked at $31.9M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Pasadena Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.